Margaret Keenan, the first out-of-trial person to receive the Pfizer coronavirus vaccine, received the second dose on Tuesday, making it the first patient to be completely immunized against the coronavirus.
Sky News reports that Keenan received his second dose at Coventry University Hospital, three weeks after the first dose was given on December 8.
Upon receiving the first dose of vaccine in early December, Keenan told reporters it was a “privilege” and “the best early birth gift I could wish for.”
“We were thrilled to receive Margaret Keenan back at Coventry University Hospital today to receive a safe dose of vaccination after she became the first person in the world to receive Pfizer COVID-19 after her clinical approval.” said Andy Hardy, executive director of Coventry University Hospital.
“It is important that everyone shows up to get the jab when invited to do so, and like other hospitals and medical offices across the country, we will follow the latest expert advice and evidence to invite people to get vaccinated at that time they need it “.
Great to see Margaret Keenan receiving the second dose of @Pfizer/@BioNTech_Group #coronavirus vaccine
We will go through this pandemic together. Http://t.co/jDZq6c0Ths
– Matt Hancock (@MattHancock) December 29, 2020
The press reports that more than 616,000 people in the UK have received their first doses of coronavirus vaccine, although British Prime Minister Boris Johnson said last week that almost 800,000 people had received a dose of vaccine.
The UK has so far only approved the Pfizer vaccine, although there have been reports that the vaccine candidate from AstraZeneca and Oxford University will be approved once this week.
Coronavirus cases in the UK are rising by a record number of cases reported on Tuesday.
In addition to the growing cases, the UK is also facing a new strain of coronavirus that has been detected.
The virus variant is more infectious, scientists said, although it does not appear to cause more severe cases of coronavirus. Health experts in the US and the UK have said that the current vaccines that have been released, as well as those of AstraZeneca, are considered effective against this new strain.
The European Union launched its immunization campaign on Sunday, encouraging citizens to receive the vaccine. It seems that the EU aims to immunize all its adults by the end of 2021.